Experts In The News

Las Vegas Sun

In the middle of the pandemic, when it seemed like business after business in Las Vegas was closing, Upbeat Health was just getting started. Today, the Summerlin clinic’s mobile wound-care team has grown nearly tenfold, one small example of how Nevada’s entrepreneurs turned crisis into opportunity.

History Channel

Although St. Valentine lends his name to Valentine’s Day, he did not become known as the patron saint of lovers until hundreds of years after his death. The third-century priest lived during a time when Christians were persecuted for their religious beliefs. Records and historic liturgical calendars indicate he was martyred, though what exactly led to his murder is a bit murky.

K.V.V.U. T.V. Fox 5

A FOX5 story into speeding on the 215 around Stephanie has generated nearly 700 comments on Facebook, with many drivers defending excessive speeds in construction zones.

Desert Companion

Mountain West law-enforcement agreements with ICE rose five-fold in 2025

Desert Companion

Over at UNLV’s Barrick Museum of Art, the National Endowment for the Arts partially funded a recent exhibit of Asian diaspora artworks, Living Here — eventually.

Las Vegas Review Journal

Whether it’s a reaction to the “Vegas is dead” narrative or a routine effort to fill hotel rooms, the city’s bid to attract customers for the Super Bowl weekend is unlike any in recent memory, with Strip rooms going for less than $100 a night and the typical luxury outlets tamping down room rates.

History Channel

Much like the origins of Valentine’s Day, the real identity of St. Valentine remains a bit of a mystery. The holiday’s namesake, a martyred priest, actually could have been one of multiple men. Although many think of him as the patron saint of lovers, this reputation likely began centuries after his death.

Nature Medicine

For decades, diagnosing Alzheimer’s disease (AD) has required access to specialist memory clinics, neuroimaging or invasive cerebrospinal fluid (CSF) testing. That paradigm is starting to shift. In 2025, the US Food and Drug Administration (FDA) cleared the first blood-based biomarker tests intended to aid the assessment of AD.